Yan Chen
Los Angeles
Education
Ph.D., epidemiology, University of Washington; M.H.S., epidemiology, Johns Hopkins Bloomberg School of Public Health; B.S., pharmaceutical sciences, Fudan University
Summary of Experience
Dr. Chen is an epidemiologist with broad experience in health economics and outcomes research (HEOR) across a wide range of therapeutic areas, including oncology, nephrology, rheumatology, cardiology, and infectious diseases. He specializes in using both quantitative and qualitative methods to assess clinical and economic burdens of various health conditions and diseases and to compare clinical effectiveness, safety, and economic value across different treatments. Dr. Chen’s work includes real-world evidence (RWE) generation using administrative claims and electronic health records, post-hoc analysis of clinical trial data, systematic literature review and network meta-analysis, and health economic modeling. His recent projects supported regulatory submissions of COVID-19 treatments in multiple regions. His research has been published in peer-reviewed journals and presented at clinical and economic conferences.
Selected Publishing
-
Real-World Comparative Effectiveness of Acalabrutinib and Ibrutinib in Patients with Chronic Lymphocytic Leukemia
Blood Advances, 2023
2023Roeker LE, DerSarkissian M, Ryan K, Chen Y, Duh MS, Wahlstrom SK, Hakre S, Yu L, Guo H, Mato A
-
Nivolumab versus placebo as adjuvant therapy for resected stage III melanoma: a propensity weighted indirect treatment comparison and number needed to treat analysis for recurrence-free survival and overall survival
Cancer Immunology, Immunotherapy, 2022
2022Weber JS, Poretta T, Stwalley BD, Sakkal LA, Du EX, Wang T, Chen Y, Wang Y, Betts KA, Shoushtari AN
-
CKD Progression and Economic Burden in Individuals with CKD Associated with Type 2 Diabetes
Kidney Medicine, 2022
2022Mullins CD, Pantalone KM, Betts KA, Song J, Wu A, Chen Y, Kong SX, Singh R